AMANDA KWAN: Open Payments
NPI 1992150817 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 16 payments from 12 companies in 2025. Trend: 2023 $1,064 · 2024 $919 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Integra LifeSciences Corporation | 1 | $106 |
| PolyNovo North America LLC | 3 | $92 |
| Aroa Biosurgery Incorporated | 1 | $74 |
| Actelion Pharmaceuticals US, Inc. | 1 | $67 |
| Kerecis Limited | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Innovation Technologies Inc | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $24 |
| AtriCure, Inc. | 1 | $18 |
Products named: Integra, NOVOSORB BTM, UPTRAVI, Kerecis SurgiClose, KEYTRUDA QLEX, IRRISEPT, NUZYRA, Kimyrsa.
Industry payments across LA — which companies pay providers there.
